(VIANEWS) – VERALLIA (VRLA.PA), BOUVET (BOUV.OL), AIRBUS (AIR.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. VERALLIA (VRLA.PA)
19.7% sales growth and 44.03% return on equity
Verallia Société Anonyme produces and sells glass packaging products for beverages and food industry worldwide. It also provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. The company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. Verallia Société Anonyme was founded in 1827 and is based in Courbevoie, France.
Earnings Per Share
As for profitability, VERALLIA has a trailing twelve months EPS of €4.08.
PE Ratio
VERALLIA has a trailing twelve months price to earnings ratio of 8.8. Meaning, the purchaser of the share is investing €8.8 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.03%.
More news about VERALLIA.
2. BOUVET (BOUV.OL)
9.7% sales growth and 60.9% return on equity
Bouvet ASA provides IT and digital communication consultancy services for public and private sector companies in Norway, Sweden, and internationally. Bouvet ASA was founded in 1995 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, BOUVET has a trailing twelve months EPS of kr3.15.
PE Ratio
BOUVET has a trailing twelve months price to earnings ratio of 19.27. Meaning, the purchaser of the share is investing kr19.27 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.9%.
Moving Average
BOUVET’s value is below its 50-day moving average of kr63.78 and below its 200-day moving average of kr62.05.
Sales Growth
BOUVET’s sales growth is 12.3% for the ongoing quarter and 9.7% for the next.
Volume
Today’s last reported volume for BOUVET is 4250 which is 88.05% below its average volume of 35579.
Earnings Before Interest, Taxes, Depreciation, and Amortization
BOUVET’s EBITDA is 40.45.
More news about BOUVET.
3. AIRBUS (AIR.PA)
7% sales growth and 26.56% return on equity
Airbus SE engages in the design, manufacture, and delivery of aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft; freighter aircraft; and regional turboprop aircraft and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment engages in the development, manufacture, marketing, and sale of civil and military helicopters; and provision of helicopter related services. The Airbus Defence and Space segment designs, develops, delivers, and supports military aircraft, such as combat, mission, transport, tanker aircraft, and their associated services; a range of civil and defence space systems for telecommunications, earth observations, navigation, science, and orbital systems; and unmanned aerial systems. This segment also offers missile and space launcher systems, as well as services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. Airbus SE was incorporated in 1998 and is based in Leiden, the Netherlands.
Earnings Per Share
As for profitability, AIRBUS has a trailing twelve months EPS of €5.08.
PE Ratio
AIRBUS has a trailing twelve months price to earnings ratio of 27.55. Meaning, the purchaser of the share is investing €27.55 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.56%.
More news about AIRBUS.
4. DASSAULT SYSTEMES (DSY.PA)
7% sales growth and 13.44% return on equity
Dassault Systèmes SE provides software solutions and services worldwide. It offers SOLIDWORKS design software for mechanical and electronic printed circuit board design solutions, product data management, simulation, manufacturing, and technical communication; CATIA, an engineering and design software for product 3D computer-aided design; GEOVIA for intersection of natural resources, infrastructure and urban planning; and BIOVIA that develops chemicals, biologics, and materials experiences. The company provides SIMULIA that delivers realistic simulation applications; DELMIA, which enables global industrial operations; 3DVIA that provides 3D space planning solutions; and ENOVIA that enables to plan and track the definition of success for customer. In addition, it offers Centric PLM, a product lifecycle management software solution; 3DEXCITE, a real-time 3D visualization software; NETVIBES, which enables organizations to gather, align, and enrich big data; 3DEXPERIENCE platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and MEDIDATA, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. It primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; energy and materials; home and lifestyle; construction, cities, and territories; consumer packaged goods and retail; marine and offshore; and business services. Dassault Systèmes SE was incorporated in 1981 and is headquartered in Vélizy-Villacoublay, France.
Earnings Per Share
As for profitability, DASSAULT SYSTEMES has a trailing twelve months EPS of €0.78.
PE Ratio
DASSAULT SYSTEMES has a trailing twelve months price to earnings ratio of 57.21. Meaning, the purchaser of the share is investing €57.21 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.44%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 8.8% and 7.1%, respectively.
Sales Growth
DASSAULT SYSTEMES’s sales growth is 5.5% for the present quarter and 7% for the next.
Volume
Today’s last reported volume for DASSAULT SYSTEMES is 261660 which is 77.77% below its average volume of 1177110.
More news about DASSAULT SYSTEMES.
5. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 16.03% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 23.5. Meaning, the purchaser of the share is investing kr23.5 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.
Volume
Today’s last reported volume for VISTIN PHARMA is 10784 which is 40.48% below its average volume of 18120.
Moving Average
VISTIN PHARMA’s worth is higher than its 50-day moving average of kr22.63 and higher than its 200-day moving average of kr22.27.
Revenue Growth
Year-on-year quarterly revenue growth grew by 30.8%, now sitting on 438.54M for the twelve trailing months.
More news about VISTIN PHARMA.
